Home > Insider Trading > Filing (0000899243-17-022122)

Filing Details

Accession Number:: 0000899243-17-022122
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-09-15 13:30:26
Reporting Period:: 2017-09-13

Accepted Time:: 2017-09-15 13:30:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1434647	Kempharm Inc	KMPH	()	4

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1083033	G Andrew Bluhm	900 North Michigan Suite 1600 Chicago IL 60611	No	No	Yes	No
1299434	Dsc Advisors, L.p.	900 North Michigan Suite 1600 Chicago IL 60611	No	No	Yes	No
1648574	Dsc Advisors, L.l.c.	900 North Michigan Suite 1600 Chicago IL 60611	No	No	Yes	No
1648576	Delaware Street Capital Master Fund, L.p.	900 North Michigan Suite 1600 Chicago IL 60611	No	No	Yes	No
1648612	Dsc Managers, L.l.c.	900 North Michigan Suite 1600 Chicago IL 60611	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock, Par Value $0.0001	Acquisiton	2017-09-13	186,831	$3.25	1,652,574	No	4	P	Direct
Common Stock, Par Value $0.0001	Acquisiton	2017-09-13	200	$3.25	1,652,774	No	4	P	Direct
Common Stock, Par Value $0.0001	Acquisiton	2017-09-14	138,857	$3.30	1,791,631	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The filing of this Form 4 shall not be construed as an admission that DSC Advisors, L.P. ("DSCA), the investment manager of Delaware Street Master Fund, L.P. (the "Fund"), DSC Managers, L.L.C. ("DSCM"), the general partner of the Fund, DSC Advisors, L.L.C. ("DSCA LLC"), the general partner of DSCA, or Andrew G. Bluhm, the principal of DSCA LLC, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the Common Stock, par value $0.0001 (the "Common Stock"), of KemPharm, Inc. (the "Issuer") purchased by the Fund. Pursuant to Rule 16a-1, each of DSCA, DSCM, DSCA LLC and Mr. Bluhm disclaim such beneficial ownership.
The Fund holds the shares of Common Stock directly. DSCA serves as the investment manager to the Fund. DSCA LLC serves as the general partner of DSCA. DSCM receives a portion of the profits in the form of a capital allocation from, and owns a partnership interest in, the Fund. Andrew G. Bluhm reports the Common Stock held directly by the Fund because, as the principal of DSCA LLC at the time of purchase, he controlled the disposition and voting of the securities.
The purchase price represents a weighted average of the purchase price for multiple transactions on the same trading day. The range of purchase prices was $3.15 to $3.30. The Reporting Persons will provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
The purchase price represents a weighted average of the purchase price for multiple transactions on the same trading day. The range of purchase prices was $3.25 to $3.35. The Reporting Persons will provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.